Decision Support Tool
Predict Prostate Tool
A web-based tool that can help some men with early prostate cancer compare the estimated long-term outcomes of monitoring and treatment options.
Predict Prostate is intended for men with non-metastatic prostate cancer who are deciding between Active Surveillance and treatment options.
No tool can tell an individual man exactly what will happen in the future. Predict Prostate is designed to provide a realistic estimate, or “best guess,” about the potential survival benefits of different options after a diagnosis of early prostate cancer.
What the tool estimates
The Predict Prostate tool provides individualized estimates of cancer-specific and overall long-term survival for men with prostate cancer. It can also help compare the possible survival benefit of different treatment options.
The tool is designed for newly diagnosed men with early prostate cancer, including men with low-risk and intermediate-risk prostate cancer.
Information used by Predict Prostate
Predict Prostate uses routinely available clinical and pathology information to create its estimates. This may include:
- PSA level
- Biopsy Gleason score or ISUP grade group
- Cancer stage
- Age and general health or comorbidity status
- Whether a person is considering monitoring, surgery, or radiotherapy
The tool also includes information about possible side effects and outcomes that can occur after a treatment decision.
How to use it thoughtfully
Predict Prostate may be most helpful when used as part of a conversation with your doctor. It can give you a clearer sense of the estimated difference between options, but it should not be used as the only basis for a decision.
You can access the web tool directly at prostate.predict.nhs.uk, or search for Predict Prostate on a web-enabled device.
You can also read Howard Wolinsky’s article about the tool here: Predicting PCA prognosis with Predict Prostate.
Important note
Predict Prostate is a decision support tool, not a replacement for medical advice. Your own results, priorities, health history, pathology details, imaging results, and comfort with monitoring or treatment should all be discussed with your healthcare team.
For more ASPI resources, you may also want to visit The Pathway, our Glossary, or our Evidence and Guidelines page.